Dinova, Ascendum Capital and Metronom Health launch joint venture in China

Dinova Medtech, Ascendum Capital, and Metronom Health established a joint venture in China to develop, manufacture and sell Metronom's continuous glucose monitoring system in China.

“Dinova Medtech, a highly specialized medical device innovation hub, with Ascendum Capital, a new healthcare-focused investment platform, and Metronom Health, an innovative U.S. developer of a continuous glucose monitoring (CGM) system, have established a joint venture in China.”prnewswire.com

• 1 source
• prnewswire.comDinova and Metronom Health, an innovative glucose monitoring company, announces launch of a joint venture in ChinaDinova MedtechMay 18, 2021

Summarized from public sources; check the original articles before acting on it.